WADE JEFFREY L

CIK 00012257671 companyTHE WOODLANDS, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001225767

Recent Transactions

50 trades

Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2024-07-08+307,000→ 307,000 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-02-28+37,274→ 312,792 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2024-02-28−49,113→ 98,227 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2024-02-28−37,274→ 37,273 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2024-02-28−11,177→ 0 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-02-28+49,113→ 361,905 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-02-28+11,177→ 275,518 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-02-28$2.62/sh−37,691→ 324,214 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2024-02-08+314,320→ 314,320 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2024-02-08+314,320→ 314,320 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-09-14$1.38/sh+10,000→ 264,341 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-20$2.33/sh+10,000→ 252,341 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-20$2.33/sh+2,000→ 254,341 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-02-28+11,176→ 235,323 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-02-28+37,273→ 272,596 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-02-28+30,467→ 224,147 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2023-02-28−30,467→ 0 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2023-02-28−11,176→ 11,177 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2023-02-28−37,273→ 74,547 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-02-28$2.17/sh−30,255→ 242,341 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2023-02-09+442,030→ 442,030 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2023-02-09+147,340→ 147,340 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2022-02-28+11,177→ 219,453 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2022-02-28+30,466→ 208,276 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2022-02-28+25,290→ 177,810 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2022-02-28−11,177→ 22,353 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2022-02-28−30,466→ 30,467 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2022-02-28−25,290→ 0 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2022-02-28$2.85/sh−25,773→ 193,680 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2022-02-10+335,470→ 335,470 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2022-02-10+111,820→ 111,820 total
Gift
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-04-14−4,500→ 152,520 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-28−25,290→ 25,290 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28+2,797→ 118,292 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-28−30,467→ 60,933 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28+25,290→ 153,137 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-28−9,555→ 0 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-28−2,797→ 0 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28$7.19/sh−26,584→ 157,020 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28+30,467→ 183,604 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28+9,555→ 127,847 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-11+33,530→ 33,530 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2021-02-11+100,600→ 100,600 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2020-04-22+26,525→ 125,146 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2020-04-22$1.96/sh−9,651→ 115,495 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2020-02-28+4,495→ 77,003 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2020-02-28−2,798→ 2,797 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2020-02-28−25,290→ 50,580 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2020-02-28+9,555→ 89,356 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2020-02-28+25,290→ 114,646 total

Companies

LEXICON PHARMACEUTICALS, INC.
EVP, Gen. Counsel
$LXRX

Recent Filings

Address

8800 TECHNOLOGY FOREST PLACE

THE WOODLANDS, TX, 773811160

View on SEC.gov